Furthermore, evidence from animal studies is supported by observations from human studies, which reported beneficial effects of AT1R blockers and angiotensin-converting enzyme (ACE) inhibitors in treating diabetic patients with heart failure [22,23]. The gene discussed is ACE; the disease is heart failure.